After Ottman Azzaitar was excluded from the UFC, another decision fell, this time involving his older brother Abu Azaitar.
The US Anti-Doping Agency USADA suspended the fighter for 7 months, starting August 25, after four positive tests for tamoxifen. The Moroccan fighter was able to prove that the substance had been prescribed to him by a doctor, and thus ended up with a reduced suspension.
USADA ruled, however, that Azaitar did not qualify for a therapeutic use authorization. The Moroccan will be able to return to the octagon on March 25.
Tamoxifen is an estrogen receptor modulator. It is mainly used as a treatment for breast cancer and can also be prescribed for men in special cases.